"Cambridge Cardiac Care Centre is a full-service diagnostic and therapeutic facility providing Non-invasive cardiac services. It is the designated provider of Cardiac Rehabilitation services, rapid access congestive heart failure & Afib services to Cambridge Memorial Hospital & Waterloo Wellington Region. Our services including diagnostic testing, lifestyle and dietary counseling, exercise supervision and rehabilitation as well as advanced therapeutics at all stages of heart disease from prevention to disease management and rehabilitation after heart attacks or other acute events or procedures. We are actively involved in clinical research to advance the understanding and management of heart disease with the goal of eliminating this scourge"

During the past decade, Cambridge Cardiac Care Centre conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cambridge Cardiac Care Centre" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Milestone Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cambridge Cardiac Care Centre" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Cambridge Cardiac Care Centre" are "Heart Failure" (5 trials), "Cardiovascular Disease" (3 trials), "Myocardial Infarction" (3 trials), "Atherosclerosis" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Cambridge Cardiac Care Centre" in a lesser frequency.

Most popular intervention types in "Cambridge Cardiac Care Centre" are "Drug" (19 trials), "Other" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (3 trials), "Darusentan" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cambridge Cardiac Care Centre" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Cambridge Cardiac Care Centre". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Cambridge Cardiac Care Centre, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Cambridge Cardiac Care Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".